2.5 ml tirzepatide (Mounjaro) leads to substantial weight loss in diabetes patients Zepbound Tirzepatide Injection 2.5 Mg

GLP-1 programs are a clear example, but the same applies to: Hormone optimization Functional medicine care plans IV therapy programs Longevity treatments These arent isolated visits

Industry Size (2025) USD 4.1 Bn Forecast (2035) USD 13 Bn CAGR (2025 to 2035) 12.2% GLP-1 Nutritional Support Market Size, Share, and Forecast Outlook 2025 to 2035 The GLP-1 nutritional support market is forecast to reach USD 13 billion by 2035, up from USD 4.1 billion in 2025, advancing at a 12.2% CAGR

variants in the GIPR gene (rs1800437) influence glucose and hunger responses

For you as a coach, this means no inventory, no fulfillment headaches, and consistent patient access